1. Home
  2. RPT vs IRWD Comparison

RPT vs IRWD Comparison

Compare RPT & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPT
  • IRWD
  • Stock Information
  • Founded
  • RPT 2014
  • IRWD 1998
  • Country
  • RPT United States
  • IRWD United States
  • Employees
  • RPT N/A
  • IRWD N/A
  • Industry
  • RPT
  • IRWD Biotechnology: Pharmaceutical Preparations
  • Sector
  • RPT
  • IRWD Health Care
  • Exchange
  • RPT NYSE
  • IRWD Nasdaq
  • Market Cap
  • RPT 121.7M
  • IRWD 124.0M
  • IPO Year
  • RPT N/A
  • IRWD 2010
  • Fundamental
  • Price
  • RPT $2.72
  • IRWD $0.75
  • Analyst Decision
  • RPT Strong Buy
  • IRWD Buy
  • Analyst Count
  • RPT 1
  • IRWD 5
  • Target Price
  • RPT $4.00
  • IRWD $4.94
  • AVG Volume (30 Days)
  • RPT 399.6K
  • IRWD 1.8M
  • Earning Date
  • RPT 08-16-2025
  • IRWD 08-07-2025
  • Dividend Yield
  • RPT 8.81%
  • IRWD N/A
  • EPS Growth
  • RPT N/A
  • IRWD N/A
  • EPS
  • RPT N/A
  • IRWD N/A
  • Revenue
  • RPT N/A
  • IRWD $317,676,000.00
  • Revenue This Year
  • RPT N/A
  • IRWD N/A
  • Revenue Next Year
  • RPT $19.21
  • IRWD N/A
  • P/E Ratio
  • RPT N/A
  • IRWD N/A
  • Revenue Growth
  • RPT N/A
  • IRWD N/A
  • 52 Week Low
  • RPT $2.29
  • IRWD $0.53
  • 52 Week High
  • RPT $3.86
  • IRWD $7.11
  • Technical
  • Relative Strength Index (RSI)
  • RPT N/A
  • IRWD 54.95
  • Support Level
  • RPT N/A
  • IRWD $0.70
  • Resistance Level
  • RPT N/A
  • IRWD $0.77
  • Average True Range (ATR)
  • RPT 0.00
  • IRWD 0.06
  • MACD
  • RPT 0.00
  • IRWD 0.01
  • Stochastic Oscillator
  • RPT 0.00
  • IRWD 72.44

About RPT RITHM PROPERTY TRUST INC

Rithm Property Trust Inc is a real estate investment trust (REIT) externally managed by an affiliate of Rithm Capital Corp. (Rithm). The group is embarking on a new commercial real estate-focused investment. Its tailored approach to investment management seeks to generate attractive risk-adjusted returns for stockholders over the long term through dividends and capital appreciation.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: